May 18, 2020 / 11:45 AM / 18 days ago

BRIEF-Provention Bio And Vactech Announce Publication Of Proof-Of-Concept Data For A Preclinical Prototype Of Coxsackievirus B Vaccine

May 18 (Reuters) - Provention Bio Inc:

* PROVENTION BIO AND VACTECH ANNOUNCE PUBLICATION OF PROOF-OF-CONCEPT DATA FOR A PRECLINICAL PROTOTYPE OF COXSACKIEVIRUS B VACCINE

* PROVENTION BIO INC - PRECLINICAL PROTOTYPE OF COXSACKIEVIRUS B VACCINE IS WELL-TOLERATED

* PROVENTION BIO - PRECLINICAL PROTOTYPE VACCINE PROVIDES STRONG PROTECTION AGAINST COXSACKIEVIRUS B INFECTIONS AND DIABETES IN RELEVANT ANIMAL MODELS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below